Last reviewed · How we verify

NCT05858554: Coelios

The Safety of Direct Laparoscopic Introduction: Retrospective Observational Study at the University Hospital of Strasbourg

Status unknown Last updated 2 November 2023
What this trial tests

trial in Laparoscopy in 100 participants. Status unknown.

Timeline
19 April 2023
Primary endpoint
19 December 2023
19 December 2023

Quick facts

Lead sponsorUniversity Hospital, Strasbourg, France
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date19 April 2023
Primary completion19 December 2023
Estimated completion19 December 2023
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Strasbourg, France

Who can join

18 and older, female only, with Laparoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Veress techniques and open laparoscopy are the techniques most used by gynecological surgeons to date. Advantages of the direct introduction unknown because technique still little used. The research hypothesis is that very few major complications are expected showing the safety of direct introduction. A look back at the practice of direct introduction into laparoscopy from 2012 to 2022 at the CMCO (Medical-Surgical and Obstetrical Center of Strasbourg)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laparoscopy

Currently open trials in the same condition.

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05858554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing